Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Olema Pharmaceuticals stock in Canada | $28

Own Olema Pharmaceuticals shares in just a few minutes.

Olema Pharmaceuticals is a biotechnology business based in the US. Olema Pharmaceuticals stocks (OLMA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.86 – an increase of 4.48% over the previous week. Olema Pharmaceuticals employs 36 staff and has a market cap (total outstanding stock value) of $1.1 billion.

How to buy shares in Olema Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OLMA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Olema Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Olema Pharmaceuticals stock price

Use our graph to track the performance of OLMA stocks over time.

Olema Pharmaceuticals shares at a glance

Information last updated 2021-10-23.
Latest market close$28.00
52-week range$19.41 - $60.27
50-day moving average $28.57
200-day moving average $27.70
Wall St. target price$55.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.03

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Trading Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Olema Pharmaceuticals price performance over time

Historical closes compared with the close of $28 from 2021-10-25

1 week (2021-10-19) 4.48%
1 month (2021-09-24) -1.65%
3 months (2021-07-26) 19.50%
6 months (2021-04-26) -9.71%
1 year (2020-10-22) N/A
2 years (2019-10-22) N/A
3 years (2018-10-22) N/A
5 years (2016-10-22) N/A

Olema Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -7.85%
Return on equity TTM -13.13%
Profit margin 0%
Book value $8.26
Market capitalisation $1.1 billion

TTM: trailing 12 months

Shorting Olema Pharmaceuticals shares

There are currently 2.4 million Olema Pharmaceuticals shares held short by investors – that's known as Olema Pharmaceuticals's "short interest". This figure is 8.3% up from 2.2 million last month.

There are a few different ways that this level of interest in shorting Olema Pharmaceuticals shares can be evaluated.

Olema Pharmaceuticals's "short interest ratio" (SIR)

Olema Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Olema Pharmaceuticals shares currently shorted divided by the average quantity of Olema Pharmaceuticals shares traded daily (recently around 382417.43264659). Olema Pharmaceuticals's SIR currently stands at 6.31. In other words for every 100,000 Olema Pharmaceuticals shares traded daily on the market, roughly 6310 shares are currently held short.

However Olema Pharmaceuticals's short interest can also be evaluated against the total number of Olema Pharmaceuticals shares, or, against the total number of tradable Olema Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Olema Pharmaceuticals's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Olema Pharmaceuticals shares in existence, roughly 60 shares are currently held short) or 0.0976% of the tradable shares (for every 100,000 tradable Olema Pharmaceuticals shares, roughly 98 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Olema Pharmaceuticals.

Olema Pharmaceuticals share dividends

We're not expecting Olema Pharmaceuticals to pay a dividend over the next 12 months.

Olema Pharmaceuticals overview

Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site